SENNA- sennosides 8.6 mg tablets tablet 
AACE PHARMACEUTICALS, INC.

----------

SPL UNCLASSIFIED SECTION

Senna Tablets

Sennosides 8.6 mg

AACE Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

ACTIVE INGREDIENT (IN EACH TABLET)

Sennosides 8.6 mg

PURPOSE

Laxative

USES

WARNINGS

Do not use

  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS

agestarting dosagemaximum dosage
adults and children 12 years of age or older2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a docto

OTHER INFORMATION

INACTIVE INGREDIENTS

colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid

PRINCIPAL DISPLAY PANEL

​†Compare to the active ingredient in Senokot®

Senna Tablets

Sennosides 8.6 mg

Natural Vegetable Laxative

Gentle, Overnight Relief of Constipation

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Manufactured by:

AACE Pharmaceuticals, Inc. Fairfield, NJ 07004

aacepharma.com

†This product is not manufactured or distributed by Purdue Products L.P., owner of the registered trademark Senokot®.

Senna 1000

NDC 71406-105-01

SENNA 
sennosides 8.6 mg tablets tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71406-105
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
Product Characteristics
Colorbrown (Light brown to grey) Scorescore with uneven pieces
ShapeROUNDSize9mm
FlavorImprint Code S5
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71406-105-01100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product08/30/2019
2NDC:71406-105-101000 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product08/30/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00708/30/2019
Labeler - AACE PHARMACEUTICALS, INC. (080630748)

Revised: 11/2024
Document Id: 26558381-3394-7d7b-e063-6394a90acfa7
Set id: 91320afc-2eec-692f-e053-2a95a90a3616
Version: 7
Effective Time: 20241107
 
AACE PHARMACEUTICALS, INC.